亞太區股市隨美股全面造好 台股續漲3.4%屢創逾30年高 港韓股升1.4%-1.9%
阿思達克 07-28 09:24
美股昨晚扭兩連跌全面反覆回升0.4%-1.7%，美國疫情持續反彈，但Moderna研發新冠肺炎疫苗開始進入最後階段大規模臨床測試，若測試成功，料年底可廣泛使用，股價急漲9%，加上美國6月核心耐用品訂單及達拉斯聯儲製造業指數升幅均勝預期，市場也憧憬美國政府將會推出新一輪刺激經濟措施，過半藍籌造好，微軟、思科、卡特彼勒、3M、蘋果、默克及陶氏升逾1-3%，但Travelers、摩通、雷神、波音及上周五已急跌英特爾跌1.4%-2%，拖累道指僅反覆回升0.4%收26,584；費城半導體指數急彈3.2%，fb、亞馬遜及Alphabe也升逾1%，帶動標普及納指彈0.7%及1.7%。不過，歐洲疫情反彈，歐洲主要股市除7月Ifo商業景氣指數升至五個月高的DAX逆穩外，全部續受壓，尤其是疫情急彈西班牙續挫1.7%。
美股期貨全面續彈0.4%-0.5%。亞太區股市早段全部向好，尤其是韓股續升1.9%報2,259；台灣加權指數延續昨天回升2.3%破頂強勢，今早再急升3.4%報13,021，屢創30年半高；澳洲200續彈1%報6,106；新加坡及新西蘭股價回升0.5%及0.7%，分別報2,589及11,669；馬股微彈0.2%報1,594。
美匯指數跌破94曾低見93.476創逾兩年低，美元兌日圓連跌第三天，報105.12屢創逾四個月低，日經扭兩連跌，回升0.5%，報22,832。滬指及深成繼昨天反覆微彈後，今天高開近0.7%及1%，分別報3,226及13,107。
本港昨天新增145宗新型肺炎確診再創單日新高，其中142宗屬本地感染。此外，本港6月出口額同比意外續降1.3%，市場原預期彈4.2%，進口額年降明顯收窄至7.1%，優於市場預期彈5.5%。期內，貿易逆差333億元，超出市場預期貿赤302億元。港股繼昨天反彈受制二萬五關倒跌逾百點後，今早扭兩連跌，在三大保險股、港交所(00388.HK)及重磅股騰訊(00700.HK)高開逾1%-2.8%帶動，高開339點或1.4%報24,942。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
